to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Lestaurtinib, a multitargeted tyrosine kinase inhibitor: from bench to bedside.
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.
fms-Like Tyrosine Kinase 3
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Protein Tyrosine Kinases